- Trials with a EudraCT protocol (53)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
53 result(s) found for: Uveal Diseases.
Displaying page 1 of 3.
EudraCT Number: 2013-000564-29 | Sponsor Protocol Number: SUGBG-013001 | Start Date*: 2013-04-25 |
Sponsor Name:Sahlgrenska University Hospital | ||
Full Title: The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases | ||
Medical condition: Uveal melanoma liver metastases | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-007847-28 | Sponsor Protocol Number: DERMA-ER-DC08 | Start Date*: 2011-09-16 | |||||||||||
Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
Full Title: A multicenter, randomized, two-armed, open-label Phase III study to evaluate the adjuvant vaccination with tumor RNA-loaded autologous Dendritic Cells versus observation of patients with resected m... | |||||||||||||
Medical condition: Patients with resected uveal melanoma showing monosomy 3, free of metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002439-32 | Sponsor Protocol Number: SirTac2014 | Start Date*: 2015-10-22 |
Sponsor Name:Charité – Universitätsmedizin Berlin | ||
Full Title: A Randomized Phase II Trial of Transarterial Radioembolization with Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolization with Cisplatin (TACE) in Patients with Liver Metastases from U... | ||
Medical condition: Liver Metastases from Uveal Melanoma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003188-24 | Sponsor Protocol Number: CA184-587 | Start Date*: 2020-11-13 | |||||||||||
Sponsor Name:Sahlgrenska University Hospital | |||||||||||||
Full Title: A Phase I Randomized Controlled Multicentre Trial of Isolated Hepatic Perfusion in Combination with Ipilimumab and Nivolumab in Patients with Uveal Melanoma Metastases | |||||||||||||
Medical condition: Metastatic uveal melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002474-99 | Sponsor Protocol Number: GEM-2101 | Start Date*: 2022-09-07 | |||||||||||
Sponsor Name:Grupo Español Multidisciplinar de Melanoma (GEM) | |||||||||||||
Full Title: Phase II, Open-Label Study of preliminary efficacy of Sitravatinib in Combination with Tislelizumab in Patients with Metastatic Uveal Melanoma with liver metastases. | |||||||||||||
Medical condition: Metastatic Uveal Melanoma with liver metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000281-11 | Sponsor Protocol Number: CMEK162X2203 | Start Date*: 2013-07-15 |
Sponsor Name:Novartis Pharma Services | ||
Full Title: A phase Ib/II, open-label, multicenter study of AEB071 and MEK162 in adult patients with metastatic uveal melanoma | ||
Medical condition: Uveal Melanoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) NL (Completed) ES (Completed) GB (Prematurely Ended) IT (Temporarily Halted) | ||
Trial results: View results |
EudraCT Number: 2018-004248-49 | Sponsor Protocol Number: NL69508.058.19 | Start Date*: 2020-02-26 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Phase 1b/2 Study Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced Uveal Melanoma (CHOPIN) | ||
Medical condition: Metastatic uveal melanoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003380-95 | Sponsor Protocol Number: CDYP688A12101 | Start Date*: Information not available in EudraCT | |||||||||||||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||||||||||||
Full Title: A Phase I/II, multi-center, open label study of DYP688 in patients with metastatic uveal melanoma (MUM) and other GNAQ/11 mutant melanomas | |||||||||||||||||||||||
Medical condition: MUM and other non-uveal, GNAQ/11 mutant melanomas | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Ongoing) NL (Ongoing) ES (Ongoing) NO (Ongoing) IT (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004429-15 | Sponsor Protocol Number: GEM-1402 | Start Date*: 2016-02-16 | |||||||||||
Sponsor Name:GRUPO ESPAÑOL MULTICISPLINAR DE MELANOMA | |||||||||||||
Full Title: Phase II multicente, non randomized, open label trial of nivolumab in combination with ipilimumab in subjects with previously untreated metastatic uveal melanoma. | |||||||||||||
Medical condition: Metastatic uveal melanoma non suitable for radical resection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003545-41 | Sponsor Protocol Number: D1344C00001 | Start Date*: 2014-04-14 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Randomised, Double-Blind Study to Assess the Efficacy of Selumetinib (AZD6244, Hyd-Sulfate) in Combination with Dacarbazine Compared with Placebo in Combination with Dacarbazine as First Systemic... | |||||||||||||
Medical condition: Metastatic uveal melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) CZ (Completed) DE (Completed) NL (Completed) FI (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001045-40 | Sponsor Protocol Number: GEM-1805 | Start Date*: 2020-03-03 | |||||||||||
Sponsor Name:Grupo Español Multidisciplinar de Melanoma | |||||||||||||
Full Title: Phase II, Open-Label Study of preliminary efficacy of Durvalumab (MEDI4736) in Combination with Cediranib in Patients with Metastatic Uveal Melanoma | |||||||||||||
Medical condition: Metastatic uveal melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002114-50 | Sponsor Protocol Number: PEMDAC | Start Date*: 2018-01-15 |
Sponsor Name:Sahlgrenska University Hospital | ||
Full Title: A multicenter phase II open label study to evaluate efficacy of concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma | ||
Medical condition: Patients suffering from metastatic uveal melanoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004222-34 | Sponsor Protocol Number: IMCgp100-102 | Start Date*: 2016-03-07 | |||||||||||
Sponsor Name:Immunocore Limited | |||||||||||||
Full Title: A Phase 1/2 Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 using the Intra-patient Escalation Dosing Regimen in Patients with Advanced Uveal Melanoma | |||||||||||||
Medical condition: Advanced Uveal Melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002245-12 | Sponsor Protocol Number: EORTC 18021 | Start Date*: 2005-01-27 | |||||||||||
Sponsor Name:European Organisation for the Research and Treatment of Cancer | |||||||||||||
Full Title: Intravenous versus intra-arterial fotemustine chemotherapy in patients with liver metastases from uveal melanoma: a randomized phase III study of the EORTC Melanoma Group. | |||||||||||||
Medical condition: Uveal melanomas with specific hepatic tropism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004437-22 | Sponsor Protocol Number: UoL001077 | Start Date*: 2015-04-08 | |||||||||||
Sponsor Name:University of Liverpool | |||||||||||||
Full Title: A Randomised three-arm, open label, Phase II study of continuous Selumetinib versus continuous or interrupted Selumetinib in combination with weekly Paclitaxel in metastatic Uveal Melanoma | |||||||||||||
Medical condition: Metastatic uveal melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004200-38 | Sponsor Protocol Number: N11RFA | Start Date*: 2012-03-28 | ||||||||||||||||
Sponsor Name:NKI-AVL | ||||||||||||||||||
Full Title: Phase II study exploring safety and efficacy of the combination of ipilimumab with radiofrequency ablation (RFA) in patients with unresectable uveal melanoma liver metastasis (SECIRA-UM) | ||||||||||||||||||
Medical condition: Unresectable uveal melanoma liver metastasis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002206-52 | Sponsor Protocol Number: CD-ON-MEDI4736-1108 | Start Date*: 2012-12-05 |
Sponsor Name:MedImmune | ||
Full Title: A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects with Advanced Solid Tumors | ||
Medical condition: Advanced Solid Tumors | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) GB (Completed) DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-000961-10 | Sponsor Protocol Number: NITRO Protocol | Start Date*: 2011-12-07 | |||||||||||
Sponsor Name:Royal Liverpool and Broadgreen University Hospitals Trust | |||||||||||||
Full Title: Neoadjuvant IntraviTreal Ranibizumab treatment in high risk Ocular melanoma patients: A two stage single centre Phase II single arm study (NITRO Trial) | |||||||||||||
Medical condition: Uveal Melanoma (requiring enucleation) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002611-29 | Sponsor Protocol Number: MEL001 | Start Date*: 2012-04-04 |
Sponsor Name:Freistaat Bayern | ||
Full Title: A prospective phase I and consecutive phase II, twoarm, randomized multi-center trial of temsirolimus in combination with pioglitazone, etoricoxib and metronomic low-dose trofosfamide versus dacarb... | ||
Medical condition: metastatic melanoma or metastatic uveal carcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002037-42 | Sponsor Protocol Number: SGNS40-002 | Start Date*: 2022-03-17 | |||||||||||||||||||||
Sponsor Name:Seagen Inc. | |||||||||||||||||||||||
Full Title: An Open-label, Phase 2 Basket Study of SEA-CD40 Combination Therapies in Advanced Malignancies | |||||||||||||||||||||||
Medical condition: Melanoma; Non-small cell lung cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) SE (Completed) FR (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.